205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands

[1]  P. Chinnery,et al.  Evaluation and Treatment of Myopathies , 2015, European Journal of Human Genetics.

[2]  David Hilton-Jones,et al.  A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis , 2014, BMJ Open.

[3]  M. Rose,et al.  International Workshop : Inclusion Body Myositis , 2 – 4 December 2011 , Naarden , The Netherlands , 2013 .

[4]  I. Lundberg,et al.  193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November – 2 December 2012, Naarden, The Netherlands , 2013, Neuromuscular Disorders.

[5]  David Hilton-Jones,et al.  Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  Hanno Steen,et al.  Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis , 2013, Annals of neurology.

[7]  B. Engelen,et al.  Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis , 2013, Annals of neurology.

[8]  W. Engel,et al.  Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis , 2012, Journal of neuropathology and experimental neurology.

[9]  A. Pestronk.  Acquired immune and inflammatory myopathies: pathologic classification , 2011, Current opinion in rheumatology.

[10]  David Hilton-Jones,et al.  Long-term observational study of sporadic inclusion body myositis. , 2011, Brain : a journal of neurology.

[11]  J. Verschuuren,et al.  A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. , 2011, Brain : a journal of neurology.

[12]  T. Maisonobe,et al.  Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[13]  D. Hilton‐Jones.  Observations on the classification of the inflammatory myopathies. , 2011, Presse medicale.

[14]  David Hilton-Jones,et al.  International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009 , 2010, Neuromuscular Disorders.

[15]  Andrew G Engel,et al.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM , 2008, Neurology.

[16]  S. Marie,et al.  International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. , 2007, Arthritis and rheumatism.

[17]  A. Pestronk,et al.  Polymyositis: An overdiagnosed entity , 2004, Neurology.

[18]  R. Hughes,et al.  119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[19]  W. V. van Venrooij,et al.  Polymyositis , 2003, Neurology.

[20]  J. C. Houwelingen,et al.  Inclusion body myositis , 1998, Journal of Neurology.

[21]  A. Eisen,et al.  Inclusion body myositis , 1978, Neurology.

[22]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[23]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[24]  S. Charman,et al.  clinical severity of disease dermatomyositis and association with of histological severity in juvenile Validation of a score tool for measurement , 2013 .

[25]  C. Mazia.  A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities , 2012 .

[26]  Emery.  Diagnostic Criteria for Neuromuscular Disorders , 1997 .

[27]  Robert G. Cooper,et al.  Polymyositis and Dermatomyositis , 2022 .